Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Communications Chemistry|August 1, 2025
A bottom-up approach to find lead compounds in expansive chemical spacesÁlvaro Serrano-Morrás, Andrea Bertran-Mostazo, Marina Miñarro-Lleonar, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2010
Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitorsJiaqiang Cai, John Robinson, Simone Belshaw, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitorsJiaqiang Cai, D Jonathan Bennett, Zoran Rankovic, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer ImmunotherapyHongjun Zhang, Kun Liu, Qinglin Pu, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitorsZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitorsJiaqiang Cai, Mark Baugh, Darcey Black, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERGZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
Pageof 13